Tigecycline : the use in an universitary hospital may lead to better outcomes?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Tipo de documento: | Trabalho de conclusão de curso |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/234282 |
Resumo: | Objectives: The aim of this study was to asses the use of tigecycline in differents therapeutic schemes in an universitary hospital. Methods: A retrospective study was conducted, including data (prontuary review) of patients who used tigecycline at a tertiary teaching hospital from January/2015 to March/2018. Patients were divided into two groups: group “standard dose”, with patients using 100 mg as attack dose, followed by 50 mg of tigecycline every 12 hours; and group “high dose”, including patients who used 200 mg, followed by 100 mg every 12 hours. Results: 43 patients received high doses and 44, standard doses of tigecycline. The main etiological agents were Klebsiella pneumoniae (87%), which were recovered from different body sites. Overall in-hospital mortality was 55.2%, with no significant difference between groups (p > 0.05). Also, there was no difference between survival time (p > 0.05). Conclusion: Among patients enrolled in this study, there was no statistically significant difference in mortality between the two groups. Heterogeneity of types of infections is our major limitation. More studies are necessary to definitively elucidate influence of high dose’s based schemes in each particular type of infections. |
id |
UFRGS-2_882a367ee4c905e64d4fdc08608dd646 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/234282 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Silva, Bianca Rocha daCaierão, JulianaSouza, Monica Vinhas de2022-01-20T04:39:52Z2018http://hdl.handle.net/10183/234282001093436Objectives: The aim of this study was to asses the use of tigecycline in differents therapeutic schemes in an universitary hospital. Methods: A retrospective study was conducted, including data (prontuary review) of patients who used tigecycline at a tertiary teaching hospital from January/2015 to March/2018. Patients were divided into two groups: group “standard dose”, with patients using 100 mg as attack dose, followed by 50 mg of tigecycline every 12 hours; and group “high dose”, including patients who used 200 mg, followed by 100 mg every 12 hours. Results: 43 patients received high doses and 44, standard doses of tigecycline. The main etiological agents were Klebsiella pneumoniae (87%), which were recovered from different body sites. Overall in-hospital mortality was 55.2%, with no significant difference between groups (p > 0.05). Also, there was no difference between survival time (p > 0.05). Conclusion: Among patients enrolled in this study, there was no statistically significant difference in mortality between the two groups. Heterogeneity of types of infections is our major limitation. More studies are necessary to definitively elucidate influence of high dose’s based schemes in each particular type of infections.application/pdfengResistência a múltiplos medicamentosTigeciclinaTigecyclineMultidrug resistant bacteriaHigh doseTigecycline : the use in an universitary hospital may lead to better outcomes?info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisUniversidade Federal do Rio Grande do SulFaculdade de FarmáciaPorto Alegre, BR-RS2018Farmáciagraduaçãoinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001093436.pdf.txt001093436.pdf.txtExtracted Texttext/plain70277http://www.lume.ufrgs.br/bitstream/10183/234282/2/001093436.pdf.txt5c7e6c5ddec96a91846b5eface46548dMD52ORIGINAL001093436.pdfTexto completo (inglês)application/pdf561069http://www.lume.ufrgs.br/bitstream/10183/234282/1/001093436.pdf539ee14b739d24169c0c1a68eb2d4ebaMD5110183/2342822022-02-22 04:54:26.019573oai:www.lume.ufrgs.br:10183/234282Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2022-02-22T07:54:26Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Tigecycline : the use in an universitary hospital may lead to better outcomes? |
title |
Tigecycline : the use in an universitary hospital may lead to better outcomes? |
spellingShingle |
Tigecycline : the use in an universitary hospital may lead to better outcomes? Silva, Bianca Rocha da Resistência a múltiplos medicamentos Tigeciclina Tigecycline Multidrug resistant bacteria High dose |
title_short |
Tigecycline : the use in an universitary hospital may lead to better outcomes? |
title_full |
Tigecycline : the use in an universitary hospital may lead to better outcomes? |
title_fullStr |
Tigecycline : the use in an universitary hospital may lead to better outcomes? |
title_full_unstemmed |
Tigecycline : the use in an universitary hospital may lead to better outcomes? |
title_sort |
Tigecycline : the use in an universitary hospital may lead to better outcomes? |
author |
Silva, Bianca Rocha da |
author_facet |
Silva, Bianca Rocha da |
author_role |
author |
dc.contributor.author.fl_str_mv |
Silva, Bianca Rocha da |
dc.contributor.advisor1.fl_str_mv |
Caierão, Juliana |
dc.contributor.advisor-co1.fl_str_mv |
Souza, Monica Vinhas de |
contributor_str_mv |
Caierão, Juliana Souza, Monica Vinhas de |
dc.subject.por.fl_str_mv |
Resistência a múltiplos medicamentos Tigeciclina |
topic |
Resistência a múltiplos medicamentos Tigeciclina Tigecycline Multidrug resistant bacteria High dose |
dc.subject.eng.fl_str_mv |
Tigecycline Multidrug resistant bacteria High dose |
description |
Objectives: The aim of this study was to asses the use of tigecycline in differents therapeutic schemes in an universitary hospital. Methods: A retrospective study was conducted, including data (prontuary review) of patients who used tigecycline at a tertiary teaching hospital from January/2015 to March/2018. Patients were divided into two groups: group “standard dose”, with patients using 100 mg as attack dose, followed by 50 mg of tigecycline every 12 hours; and group “high dose”, including patients who used 200 mg, followed by 100 mg every 12 hours. Results: 43 patients received high doses and 44, standard doses of tigecycline. The main etiological agents were Klebsiella pneumoniae (87%), which were recovered from different body sites. Overall in-hospital mortality was 55.2%, with no significant difference between groups (p > 0.05). Also, there was no difference between survival time (p > 0.05). Conclusion: Among patients enrolled in this study, there was no statistically significant difference in mortality between the two groups. Heterogeneity of types of infections is our major limitation. More studies are necessary to definitively elucidate influence of high dose’s based schemes in each particular type of infections. |
publishDate |
2018 |
dc.date.issued.fl_str_mv |
2018 |
dc.date.accessioned.fl_str_mv |
2022-01-20T04:39:52Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/234282 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001093436 |
url |
http://hdl.handle.net/10183/234282 |
identifier_str_mv |
001093436 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/234282/2/001093436.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/234282/1/001093436.pdf |
bitstream.checksum.fl_str_mv |
5c7e6c5ddec96a91846b5eface46548d 539ee14b739d24169c0c1a68eb2d4eba |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1801224618522968064 |